cd11a (fluidigm)
Structured Review

Cd11a, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd11a+hi111/Anti-Human+CD11a+(HI111)-142Nd/pmc10521424-26-2-6
Average 93 stars, based on 6 article reviews
Images
1) Product Images from "Extended interval dosing of ocrelizumab modifies the repopulation of B cells without altering the clinical efficacy in multiple sclerosis"
Article Title: Extended interval dosing of ocrelizumab modifies the repopulation of B cells without altering the clinical efficacy in multiple sclerosis
Journal: Journal of Neuroinflammation
doi: 10.1186/s12974-023-02900-z
Figure Legend Snippet: Antibodies for CyTOF
Techniques Used: Concentration Assay
Related Articles
Recombinant:Article Title: Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinoma Article Snippet: (G034E3) , Fluidigm , Cat# 3141003A, RRID: AB 2687639. .. Isolation:Article Title: Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinoma Article Snippet: (G034E3) , Fluidigm , Cat# 3141003A, RRID: AB 2687639. .. Mass Cytometry:Article Title: Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinoma Article Snippet: (G034E3) , Fluidigm , Cat# 3141003A, RRID: AB 2687639. .. Software:Article Title: Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinoma Article Snippet: (G034E3) , Fluidigm , Cat# 3141003A, RRID: AB 2687639. .. |

